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Abstract Object: The object of this
study is to demonstrate the delayed
occurrence of aqueductal stenosis in
preterm infants who have suffered
from intraventricular hemorrhage
(IVH) and to try to explain the
mechanisms of this stenosis. 
Method: From January 1996 to June
2002, 1,046 premature infants were
admitted to our institution. Thirty-six
neonates suffered from grade 3 or 
4 intraventricular hemorrhage 
(Papile grading), of whom 16 died.
Twenty patients survived and a ven-
triculoperitoneal shunt was inserted
in 7 infants. Four patients underwent
a neuroendoscopic third ventriculos-
tomy. Follow-up was carried out,
twice a month during the first
2 months and subsequently twice a
year. Conclusion: In 2 children NTV
was an effective treatment for hydro-
cephalus with an average follow-up
of 29 months. The specific pattern
concerning these patients is the long
delay before obstructive hydrocepha-
lus and the visualization of de novo
obstruction with MRI. The biologi-
cal explanation must be investigated.
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Acquired aqueductal stenosis in preterm 
infants: an indication for neuroendoscopic
third ventriculostomy
Introduction
Infants delivered at less than 35 gestational weeks (GW)
are at high risk of intraventricular hemorrhage (IVH). In
the neonatal period, this hemorrhage may be complicated
with communicating hydrocephalus in 15% of cases [6].
This is commonly treated with ventriculoperitoneal
shunts. This type of communicating hydrocephalus is
due to either arachnoiditis of the basal cisterns or sclero-
sis of Pacchioni granulations.
We describe an unusual presentation of hydrocephalus
secondary to acquired aqueductal stenosis. This has not
been described before in the premature population.
Acquired aqueductal stenosis in the preterm infant
population raises the possibility of neuroendoscopic third
ventriculostomy (NTV). We report 4 patients of less than
35 GW who suffered from neonatal IVH with delayed
obstructive hydrocephalus. The supposed mechanisms of
this unusual type of hydrocephalus are discussed.
Materials and methods
This retrospective study was conducted at one center from January
1996 to June 2002.
One thousand and forty-six premature infants delivered before
35 GW were admitted to the neonatal intensive care unit of the
American Memorial Hospital of Reims. Thirty-six neonates suf-
fered from grade 3 or 4 intraventricular hemorrhage (Papile grad-
ing) [14]: 16 died (15 aged less than 26 GW, 1 aged 29 GW).
Twenty patients survived and a ventriculoperitoneal shunt was
placed in 7 infants. Four patients underwent a neuroendoscopic
third ventriculostomy. The decision to perform endoscopic ven-
triculostomy was based on radiographic data. Radiologic diagno-
sis of obstructive hydrocephalus was established by sagittal T1 or
T2 MRI sequences and fourth ventricle morphology on axial im-
ages (3 patients). For 1 patient, only CT images were available.
The normal size of the fourth ventricle, lateral ventricle dilatation
and the huge downward expansion of the third ventricle floor are
the radiologic indicators of obstructive hydrocephalus considered
in this study. Preoperative aqueductal flow sequences were not
available.
Neuroendoscopic treatment was considered successful when
no other procedure was required for hydrocephalus. Gestational
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age, birth weight, age at neuroendoscopic treatment, initial hemor-
rhage grading, therapeutic modalities and interval between birth
and neuroendoscopic treatment are reported in Table 1. Follow-up
was carried out by a pediatric neurologist and a pediatric neuro-
surgeon, twice a month during the first 2 months and subsequently
twice a year.
Results
In the immediate postnatal period, the 4 children present-
ed with communicating hydrocephalus. They were treat-
ed with CSF withdrawal in 4 cases, external shunt in 1
case, and internal shunt in 1 case. Gestational age at
birth ranged from 24 to 35 GW. Fulminant progressive
obstructive hydrocephalus evolved after 6–36 months
(average 17 months). Clinical signs of obstructive hydro-
cephalus were progressive macrocephaly (3 cases) and
symptoms consistent with elevated ICP (1 case). No
morbidity or mortality was observed after neuroendo-
scopic third ventriculostomy. The ventriculostomy was
considered successful in 2 patients and the follow-up
was 10 months in 1 and 48 months in the other. In the re-
maining 2 patients, treatment was ineffective after
1 week (case 4) and after 6 weeks (case 3).
Discussion
Intraventricular hemorrhage (IVH) is a well-known com-
plication of premature delivery and low birth weight [8,
10, 14, 22]. Initial hemorrhage occurs, usually in the ger-
minal matrix of one side, adjacent to the head of the cau-
date nucleus. Immaturity of the ependyma and vessels is
cited as an explanation for the high frequency of intra-
ventricular bleeding at this age [8, 22, 23].
The clinical presentation of intraventricular hemor-
rhage depends on the extent of bleeding. According to
Papile grading, this hemorrhage is subdivided into [14]:
Grade 1: hemorrhage limited to the germinal matrix
Grade 2: germinal matrix hemorrhage extending into the
lateral ventricle without distension
Grade 3: intraventricular hemorrhage associated with
ventricular distension
Grade 4: grade 3 with parenchymal hemorrhage beyond
the germinal matrix
Hydrocephalus usually appears 3–4 weeks after the IVH
[8]. According to the literature, hydrocephalus is due to
an intense inflammatory reaction in the subarachnoid
space. This phenomenon results in the thickening of the
basal cisterns and an obstruction of the arachnoid villi.
These lesions result in communicating hydrocephalus [8,
16, 17, 22]. With regard to communicating hydrocepha-
lus, some authors make a distinction [15] between ob-
struction of the basal cisterns and obstruction of the
arachnoid villi. The latter is apparently the cause of real
communicating hydrocephalus [15].
In this study, we described an obstructive hydrocepha-
lus with acquired aqueductal stenosis. The pattern partic-
ular to these patients is the long delay before obstructive
hydrocephalus; 17–25 months is the average time before
the hydrocephalus required treatment. In patients who
successfully underwent NTV this delay was 13.5 months.
Our hypothesis is that acquired aqueductal stenosis
may be the consequence of a progressive obstruction.
According to Sarnat [18], the ependyma does not regen-
erate at any age and it reacts to injury with a few stereo-
typical responses. The tearing of the epithelium by ven-
tricular distension carries discontinuities between cells,
filled with subventricular astrocyte processes. This glial
response can be extensive [18], leading to the formation
of nodular gliosis. Such gliosis in the periaqueductal area
may be responsible for progressive obliteration. Fibrous
intraventricular scarring, secondary to IVH, may contrib-
ute to this obstruction [9]. This gliotic reaction develops
over time, which could explain the delay in acquired
aqueductal stenosis occurrence. Similar scars and nodu-
lar gliosis can be found in infectious diseases such as
mumps [20] with acquired stenosis [9, 13]. In the 2 suc-
cessfully treated children, obstruction was observed on
sagittal MRI with wide opening of the upper extent of
the aqueduct, while obstruction was visible on the inferi-
or part (see Fig. 2).
Biological elements may also explain this progressive
obstruction. Transforming Growth Factor Beta 1 is a cy-
tokine, which is stored in the platelets and released in the
CSF following IVH. It belongs to the super-family of
Transforming Growth factors, which play a critical role
in the regulation of various cellular functions [11, 12].
TGFB 1 has the biological property of up-regulating the
genes for extra cellular matrix proteins such as fibronec-
tin and laminin. It is involved in scar formation and fi-
Table 1 Patients’ clinical characteristics (IVH intraventricular hemorrhage)
Gestational age Birth Grading Lumbar DVE Fibrinolysis Age/NTV Results Follow-up
(weeks) weight IVH puncture
Case 1 26 1,200 g 2 Yes 0 0 7 months Success 9 months
Case 2 33.5 1,400 g 3 Yes 1 1 20 months Success 38 months
Case 3 28 1,200 g 4 Yes 1 1 6 months Failure Lost
Case 4 35 2,430 g 3 Yes 1 0 36 months Failure 12 months
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brotic disease [2, 12, 19, 22]. According to Whitelaw
[22], TGFB 1 is virtually undetectable in normal neona-
tal cerebral spinal fluid (CSF). TGFB 1 concentration in-
creases after bleeding or post-hemorrhagic ventricular
dilatation. He argues that TGFB1 stimulates the produc-
tion of extracellular matrix proteins around the brain
stem and in the subarachnoid space. This “scar tissue”
blocks the exit of the fourth ventricle or the reabsorption
channels [23]. By extension, it may be supposed that this
scar could also block the lumen of the aqueduct.
We state that this stenosis is “acquired”. Indeed, in the
neonatal period, several lumbar punctures were effective
at reducing ventricular dilatation in our patients. Trans-
fontanellar echography showed marked dilatation of the
entire ventricular system and in 1 case (case 2) MRI in
the neonatal period showed a patent aqueduct (Fig. 1)
that later disappeared (Fig. 2).
In our study, 2 out of 4 neuroendoscopic procedures
were effective. Failures were probably due to the initial
selection of patients. In case 3, NTV failed 6 weeks after
the procedure. At this time we had to choose between a
second NTV or shunting and we decided to place a
shunt. Case 4 presented with clinically significant intra-
cranial hypertension 30 months after the insertion of a
ventriculoperitoneal shunt. The decision to perform an
endoscopic third ventriculostomy was based on CT,
which revealed a marked dilatation of the ventricles with
a less marked dilatation of the fourth ventricle. The diag-
nosis was obstructive hydrocephalus and NTV was per-
formed. It failed 1 week later. This example indicates the
utility of MRI with Cine study before NTV. In this popu-
lation of infants, transtentorial asymmetry on CT is not
sufficient to determine the type of hydrocephalus and
therefore the optimal treatment. According to some au-
thors, efficiency of NTV in preterm neonates is not con-
vincing [3, 4, 5, 6] and the successful procedure rate is
close to 10%. Despite these poor results, Buxton advo-
cates carrying out NTV first to try to avoid a shunt [4].
In our preterm patients, the situation is different. Treat-
ment occurs later. At this age, the results of NTV are ex-
cellent [1, 7, 21] with a success rate close to 90%. Thus,
we think that in cases of acquired aqueductal stenosis in
older preterm infants, NTV must be recommended as the
first treatment.
Conclusion
Our practice suggests that acquired mechanical obstruc-
tion of the Sylvian aqueduct must be borne in mind by
neurosurgeons involved in preterm hydrocephalus. This
hydrocephalus occurs later in the evolution of IVH. Cine
MRI is necessary to ascertain the diagnosis and to opti-
mize the treatment. In our opinion, NTV must be carried
out in such conditions as to avoid shunt insertion and
therefore shunt complications. However, the long-term
benefits must be assessed by longer follow-ups.
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Fig. 1 MRI in the neonatal period shows a patent aqueduct with-
out dilatation of the upper part
Fig. 2 MRI before NTV (at the age of 7 months). Obstructive hy-
drocephalus. MRI shows a marked dilatation of the upper part of
the aqueduct with obstruction in the inferior part
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